Default company panoramic image
3f5e537f 34e7 4a39 afc4 fedcf139fecb

Alleviate

we aim to leverage int cardiology skills and technology to radically improve outcomes for sufferers of pulmonary arterial hypertension

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Galway, Ierland
  • Currency EUR
  • Founded August 2011
  • Employees 2

Company Summary

\our customers are patients and their doctors who suffer from this terrible and debilating disease called Pulmonary Atrial Hypertension.
In conjunction with a leading team of doctors have designed device to alleviate some of the more debilating side effects of this disease. This will improve the patients quality of life and life span.

Team

  • Default avatar
    Michael Gilmore
    Mr

    Chief Executive Officer of Alleviate.

    General Manager and VP of R&D at Cappella Medical Devices Ltd. Previously worked at Boston Scientific Corporation, EV3, and SteriPack B.Sc. in Polymer Technology from Athlone Institute of Technology. Diploma in Accounting